Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients

Azza Shoaibi; Stephen Fortin; Rachel Weinstein; Jesse A. Berlin; Patrick Ryan

doi:10.1101/2020.09.23.20199463

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

View the discussion thread.

Posted September 24, 2020.

Download PDF

Supplementary Material

Data/Code

Citation Tools

Subject Area

Gastroenterology

Subject Areas

All Articles

Addiction Medicine (405)
Allergy and Immunology (714)
Anesthesia (209)
Cardiovascular Medicine (2989)
Dentistry and Oral Medicine (338)
Dermatology (254)
Emergency Medicine (447)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1058)
Epidemiology (12859)
Forensic Medicine (12)
Gastroenterology (839)
Genetic and Genomic Medicine (4663)
Geriatric Medicine (428)
Health Economics (735)
Health Informatics (2963)
Health Policy (1078)
Health Systems and Quality Improvement (1098)
Hematology (394)
HIV/AIDS (940)
Infectious Diseases (except HIV/AIDS) (14180)
Intensive Care and Critical Care Medicine (860)
Medical Education (431)
Medical Ethics (116)
Nephrology (478)
Neurology (4447)
Nursing (239)
Nutrition (653)
Obstetrics and Gynecology (820)
Occupational and Environmental Health (741)
Oncology (2313)
Ophthalmology (657)
Orthopedics (260)
Otolaryngology (329)
Pain Medicine (286)
Palliative Medicine (85)
Pathology (504)
Pediatrics (1205)
Pharmacology and Therapeutics (512)
Primary Care Research (506)
Psychiatry and Clinical Psychology (3825)
Public and Global Health (7043)
Radiology and Imaging (1561)
Rehabilitation Medicine and Physical Therapy (932)
Respiratory Medicine (927)
Rheumatology (447)
Sexual and Reproductive Health (452)
Sports Medicine (388)
Surgery (495)
Toxicology (60)
Transplantation (213)
Urology (186)

Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients

Citation Manager Formats

Subject Area